Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
07/2007
07/10/2007CA2108466C Hcv genomic sequences for diagnostics and therapeutics
07/10/2007CA2087818C Oligonucleotide analogs, their preparation and use
07/10/2007CA2060455C Reverse antimicrobial peptides, antimicrobial oligopeptides and other antimicrobial compositions, and methods of their production and use, particularly to provide protection against plant pathogens
07/05/2007WO2007075872A2 Nitroimidazole compounds
07/05/2007WO2007075794A2 Oral formulations comprising tigecycline
07/05/2007WO2007075792A1 Methods of treating gastrointestinal tract infections with tigecycline
07/05/2007WO2007075605A2 Use of beta-hydroxy-beta-methylbutyrate to modulate the imbalance in type and type 2 cytokine production
07/05/2007WO2007075281A1 Denaturant for ethanol
07/05/2007WO2007075102A1 Medicinal agent for treating viral infections
07/05/2007WO2007075094A1 New derivatives of epirubicin, their medicinal application and pharmaceuticaly acceptable forms of drugs
07/05/2007WO2007075092A1 New derivatives of epirubicin, their medicinal application and pharmaceuticals acceptable forms of drugs
07/05/2007WO2007074871A1 Novel cxcr4 antagonist and use thereof
07/05/2007WO2007074868A1 Novel arylamidine derivative, salt thereof and antifungal agent containing those
07/05/2007WO2007074859A1 Anti-c-mannosylated peptide antibody and use thereof
07/05/2007WO2007074727A1 Remedy for oral moniliasis
07/05/2007WO2007074604A1 Nanoparticle containing water-soluble non-peptidic low molecular weight substance
07/05/2007WO2007074471A1 Anti hiv-1 active bacterial and baculovirus recombinant epap-1
07/05/2007WO2007074340A1 Process for the preparation of porphyrin derivatives as antimicrobial agents by photodynamic therapy (pdt)
07/05/2007WO2007074200A1 Inhibitor of the uracil-dna glycosylase enzyme and uses thereof
07/05/2007WO2007074185A1 Antimicrobial cyclic peptides
07/05/2007WO2007074171A1 Aza heterocyclics for the treatment of malaria or aids
07/05/2007WO2007074170A2 Compositions and methods for the treatment and prevention of disease
07/05/2007WO2007073855A1 Use of adenosine a1 receptor agonists for the protection of renal cells against toxic effects caused by aminoglycosides during treatment of infectious diseases
07/05/2007WO2007073785A1 Therapeutic use of an extract from the leaves of nerium oleander
07/05/2007WO2007073703A1 Cytoprotective pharmaceutical combination which can be used in the prevention and treatment of systemic inflammatory response syndrome
07/05/2007WO2007073583A1 A method of treatment and agents useful for same
07/05/2007WO2007058392A9 Heterocyclic compound and medicinal application thereof
07/05/2007WO2007057436A3 Interferon in influenza
07/05/2007WO2007048820A3 Micronised azodicarbonamide, the preparation and use thereof
07/05/2007WO2007043094A3 6-vinyl pyrimidine and pyrimidinone derivatives and the use thereof
07/05/2007WO2007027560A3 Formulation and method for enhancement of gastrointestinal absorption of pharmaceutical agents
07/05/2007WO2007014940A8 Quinoline derivatives as antibacterical agents
07/05/2007WO2006021210A3 Binding member towards pneumolysin
07/05/2007US20070157326 Ee3-protein family and corresponding dna sequence
07/05/2007US20070155966 Heterocyclic imines such as 2,2-Dichloro-N-[2-[3-(2-chloro-6-fluorophenyl)-5-isoxazolyl]-(4-pyridyl)]Acetamide, used for prophylaxis of hepatitis C virus (HCV)
07/05/2007US20070155959 Protease inhibitor conjugates and antibodies useful in immunoassay
07/05/2007US20070155841 Preventive agent for carcinogenesis of liver cancer containing quinone-based compound as active ingredient
07/05/2007US20070155814 Immunomodulatory compositions
07/05/2007US20070155812 Thio-substituted phenbutazone compounds as anti-inflammatory, anti-viral and immunomodulatory agents
07/05/2007US20070155810 Enzyme inhibitors as bactericides for infections and enzyme inhibitors
07/05/2007US20070155756 Treatment of chemokine mediated diseases
07/05/2007US20070155740 1-(1H-Pyrazin-2-on-3-yl)-tetrahydroquinolines or tetrahydro-1,4-benzoxazines (3-(8-Bromo-6-methoxy-1,2,3,4-tetrahydroquinoline)-5-chloro-1-(1-ethylpropyl)-2(1H)-pyrazinone); affective disorder, anxiety and depression
07/05/2007US20070155734 Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
07/05/2007US20070155732 Aryl or Heteroaryl Fused Imidazole Compounds as Anti-Inflammatory and Analgesic Agents
07/05/2007US20070155724 Methods of Treating Cytokine Mediated Diseases
07/05/2007US20070155714 Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections
07/05/2007US20070155713 Nitrogen-containing heterocyclic compounds and use thereof
07/05/2007US20070155698 Oxazaborolidines as bacteria effectors
07/05/2007US20070155683 Containing a single-stranded oligonucleotide DNA molecule containing one or more CpG(s); SARS virus, hepatitis C virus, dengue virus and Japanese encephalitis, influenza virus
07/05/2007US20070155670 Pyrrolidine Melanocortin-Specific Compounds
07/05/2007US20070154995 Development of human monoclonal antibodies and uses thereof
07/05/2007US20070154986 Streptococcus pneumoniae Polynucleotides and Sequences
07/05/2007US20070154943 Methods for preventing cattle reproductive diseases
07/05/2007US20070154905 Modulators of the function of fas receptors and other proteins
07/05/2007US20070154902 Papilloma virus vaccine
07/05/2007US20070154486 Nucleic acid molecule comprising a nucleic acid sequence coding for a haemocyanin
07/05/2007US20070154468 Use of CD28-specific monoclonal antibodies for producing a pharmaceutical composition for treating virus infections
07/05/2007CA2635770A1 Inhibition of cxcr4 and/or cell motility by phenylalanine, cysteine or peptides containing said aminoacids
07/05/2007CA2635359A1 Compositions and methods for synthesizing heterocyclic therapeutic compounds
07/05/2007CA2635342A1 Cytoprotective pharmaceutical combination which can be used in the prevention and treatment of systemic inflammatory response syndrome
07/05/2007CA2634846A1 Novel arylamidine derivative, salt thereof and antifungal agent containing those
07/05/2007CA2634630A1 Process for the preparation of porphyrin derivatives as antimicrobial agents by photodynamic therapy (pdt)
07/05/2007CA2634113A1 Quinolin- 4 - one derivatives as modulators of abc transporters
07/05/2007CA2633424A1 Pharmaceutical compositions containing protein nma0939
07/05/2007CA2632262A1 Method of using .beta.-hydroxy-.beta.-methylbutyrate
07/05/2007CA2632213A1 Oral formulations comprising tigecycline
07/05/2007CA2631661A1 Nitroimidazole compounds
07/05/2007CA2631632A1 Methods of treating gastrointestinal tract infections with tigecycline
07/04/2007EP1804062A2 YKL-40 as a marker and prognostic indicator for cancers
07/04/2007EP1803811A1 Chimeric (double) decoy
07/04/2007EP1803810A1 Integrin antagonists
07/04/2007EP1803730A1 Albumin fusion proteins
07/04/2007EP1803706A1 HIV protease inhibitors based on amino acid derivatives
07/04/2007EP1803463A1 Extracts from hypericum L. species useful for the treatment of persistent tuberculosis
07/04/2007EP1803453A1 Carbamate antibiotics
07/04/2007EP1803450A1 Pharmaceutical compositions for the eradication of helicobacter pylori
07/04/2007EP1803448A2 Tasted masked veterinary solid compositions
07/04/2007EP1802650A2 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis c infection
07/04/2007EP1802643A1 Antiviral oligonucleotides
07/04/2007EP1802619A1 Inhibitors of the hiv integrase enzyme
07/04/2007EP1802327A1 Combination anti-viral compositions comprising castanospermine and methods of use
07/04/2007EP1802319A1 Lactic acid bacteria strains useful against urogenital pathogens and compositions containing same
07/04/2007EP1802318A1 Lactic acid bacteria strains useful against gastrointestinal pathogens and compositions containing same
07/04/2007EP1802315A2 Combination therapy for treating viral infections
07/04/2007EP1802311A1 4-aminophenyl morpholinone derivatives for the treatment of hepatitis c
07/04/2007EP1802302A1 NOVEL USE OF a-SYMPATHOMIMETICS HAVING A 2-IMIDAZOLINE STRUCTURE
07/04/2007EP1802297A2 Compositions and methods for treatment of disease caused by yersinia spp infection
07/04/2007EP1802291A2 Calixarene-based peptide conformation mimetics, methods of use, and methods of making
07/04/2007EP1494688A4 Use of topical compositions for the control of microbial diseases of the nail
07/04/2007EP1484971B1 Use of 4-aminopyrimidines for the antimicrobial treatment of surfaces
07/04/2007EP1412380B1 Broad spectrum antibiotic peptides of the phylloseptin family
07/04/2007EP1286964B1 Heterocyclic inhibitors of glycogen synthase kinase gsk-3
07/04/2007EP1286690B1 Use of alpha-msh and epo for the manufacture of a medicament for preventing or treating ischemic conditions
07/04/2007EP1194560B1 Antigenic neisserial peptides
07/04/2007EP1159427B1 Gp120 mutants and biological applications
07/04/2007EP1121382B9 Interferon-beta fusion proteins and uses
07/04/2007EP0994716B2 Maternal immune secretions and their use in the treatment and/or prophylaxis of conditions of the human body
07/04/2007EP0567566B2 Methods for treating tumor necrosis factor mediated diseases
07/04/2007CN1993332A Benzyltriazolone compounds as non-nucleoside reverse transcriptase inhibitors
07/04/2007CN1990874A Gene clone of hepatitis B virus front S1 region multi-epitope antigen and encoding sequence thereof